Recursion Pharmaceuticals, Inc.

RXRX stock score: 41/100

$3.80 · +2.70% · Scored Oct 26, 2026

Technical
44
Fundamental
37
News
52

The reading

Recursion Pharmaceuticals (RXRX) scores 41 out of 100, which reads weak, higher than 38% of Healthcare stocks and 21% of the 4,151 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 44, fundamentals 37.

Among the fundamentals, Fair Value at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 47 and contrarian oscillators 58.

News sentiment is neutral at 52; it is shown, not counted in the composite.

Since Jul 29, 2026 the composite has ranged from 34 to 46, and it is down 1 point over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward RXRX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

37

Pulling it up

  • Fair Value100

    Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Institutional Ownership100

    Institutional ownership measures the percentage held by professional investors.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Price to Sales Ratio0

    Price-to-Sales ratio compares market capitalization to annual revenue.

39 weighted scorers; 2 had no data today and are left out rather than counted as zero.

Technical · daily

50

Pulling it up

  • EMA 50 Cross Up100

    EMA 50 Cross Up detects when price crosses above the 50-period EMA.

  • Ichimoku Cloud90

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • ADX (14)82

    Average Directional Index (ADX) measures trend strength regardless of direction.

Holding it back

  • S&P 500 52W Comparison0

    S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • VWAP0

    Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

  • Parabolic SAR (PSAR)0

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
52

Technical score by timeframe

ChartScoreWeight
Hourly591
Daily503
Weekly412
Monthly382
Quarterly372

Composite score, last 90 days

05010041Jul 29, 2026Oct 26, 2026Jul 29, 2026: 42Jul 30, 2026: 42Jul 31, 2026: 42Aug 2, 2026: 39Aug 3, 2026: 41Aug 5, 2026: 41Aug 6, 2026: 41Aug 7, 2026: 42Aug 8, 2026: 42Aug 9, 2026: 42Aug 10, 2026: 42Aug 11, 2026: 43Aug 12, 2026: 41Aug 13, 2026: 42Aug 14, 2026: 39Aug 15, 2026: 40Aug 16, 2026: 40Aug 17, 2026: 38Aug 18, 2026: 37Aug 19, 2026: 44Aug 20, 2026: 42Aug 22, 2026: 41Aug 23, 2026: 41Aug 24, 2026: 38Aug 25, 2026: 41Aug 26, 2026: 41Aug 27, 2026: 41Aug 28, 2026: 38Aug 29, 2026: 39Aug 30, 2026: 39Aug 31, 2026: 38Sep 1, 2026: 37Sep 2, 2026: 39Sep 3, 2026: 42Sep 4, 2026: 42Sep 5, 2026: 42Sep 6, 2026: 41Sep 7, 2026: 42Sep 8, 2026: 40Sep 9, 2026: 36Sep 10, 2026: 34Sep 11, 2026: 35Sep 12, 2026: 35Sep 13, 2026: 35Sep 14, 2026: 39Sep 15, 2026: 36Sep 16, 2026: 35Sep 17, 2026: 41Sep 18, 2026: 43Sep 19, 2026: 42Sep 20, 2026: 43Sep 21, 2026: 45Sep 22, 2026: 45Sep 23, 2026: 43Sep 24, 2026: 43Sep 25, 2026: 42Sep 26, 2026: 42Sep 27, 2026: 42Sep 28, 2026: 42Sep 29, 2026: 44Sep 30, 2026: 45Oct 1, 2026: 44Oct 2, 2026: 44Oct 3, 2026: 44Oct 4, 2026: 44Oct 5, 2026: 46Oct 6, 2026: 46Oct 7, 2026: 44Oct 8, 2026: 42Oct 9, 2026: 43Oct 10, 2026: 44Oct 11, 2026: 44Oct 12, 2026: 43Oct 13, 2026: 41Oct 14, 2026: 39Oct 15, 2026: 42Oct 16, 2026: 38Oct 17, 2026: 38Oct 18, 2026: 38Oct 19, 2026: 37Oct 20, 2026: 38Oct 21, 2026: 38Oct 22, 2026: 37Oct 23, 2026: 38Oct 24, 2026: 38Oct 25, 2026: 38Oct 26, 2026: 41
Show the daily numbers
DateComposite
Oct 26, 202641
Oct 25, 202638
Oct 24, 202638
Oct 23, 202638
Oct 22, 202637
Oct 21, 202638
Oct 20, 202638
Oct 19, 202637
Oct 18, 202638
Oct 17, 202638
Oct 16, 202638
Oct 15, 202642
Oct 14, 202639
Oct 13, 202641
Oct 12, 202643
Oct 11, 202644
Oct 10, 202644
Oct 9, 202643
Oct 8, 202642
Oct 7, 202644
Oct 6, 202646
Oct 5, 202646
Oct 4, 202644
Oct 3, 202644
Oct 2, 202644
Oct 1, 202644
Sep 30, 202645
Sep 29, 202644
Sep 28, 202642
Sep 27, 202642
Sep 26, 202642
Sep 25, 202642
Sep 24, 202643
Sep 23, 202643
Sep 22, 202645
Sep 21, 202645
Sep 20, 202643
Sep 19, 202642
Sep 18, 202643
Sep 17, 202641
Sep 16, 202635
Sep 15, 202636
Sep 14, 202639
Sep 13, 202635
Sep 12, 202635
Sep 11, 202635
Sep 10, 202634
Sep 9, 202636
Sep 8, 202640
Sep 7, 202642
Sep 6, 202641
Sep 5, 202642
Sep 4, 202642
Sep 3, 202642
Sep 2, 202639
Sep 1, 202637
Aug 31, 202638
Aug 30, 202639
Aug 29, 202639
Aug 28, 202638
Aug 27, 202641
Aug 26, 202641
Aug 25, 202641
Aug 24, 202638
Aug 23, 202641
Aug 22, 202641
Aug 20, 202642
Aug 19, 202644
Aug 18, 202637
Aug 17, 202638
Aug 16, 202640
Aug 15, 202640
Aug 14, 202639
Aug 13, 202642
Aug 12, 202641
Aug 11, 202643
Aug 10, 202642
Aug 9, 202642
Aug 8, 202642
Aug 7, 202642
Aug 6, 202641
Aug 5, 202641
Aug 3, 202641
Aug 2, 202639
Jul 31, 202642
Jul 30, 202642
Jul 29, 202642

Key facts

Market cap
$2.0B
Sector
Healthcare
Industry
Biotechnology
Beta
1.03
Risk grade (1–10)
10
Next earnings
Nov 2, 2026

Biotechnology peers

CompanyMarket capScore
XNCR Xencor$2.2B50
PGEN Precigen$2.2B45
HRMY Harmony Biosciences$2.1B69
IMNM Immunome$2.1B40
VERA Vera Therapeutics$2.0B32
ZYME Zymeworks$2.0B52

Questions

What is RXRX's stock score today?

RXRX scores 41/100 (Weak) as of Oct 26, 2026: technical 44, fundamental 37, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.

Is RXRX a buy?

The score is not a buy or sell recommendation. A 41 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the RXRX score calculated?

100 weighted scorers feed it today: 39 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.